|
ZNF224 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.94609999995643E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.615500E-04 |
| Normal-vs-Stage2 |
2.398700E-04 |
| Normal-vs-Stage3 |
2.74440000003207E-06 |
| Normal-vs-Stage4 |
1.121510E-03 |
| Stage1-vs-Stage2 |
2.593000E-01 |
| Stage1-vs-Stage3 |
6.294000E-02 |
| Stage1-vs-Stage4 |
4.379200E-01 |
| Stage2-vs-Stage3 |
8.083800E-01 |
| Stage2-vs-Stage4 |
7.803200E-01 |
| Stage3-vs-Stage4 |
5.782400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.60255999999137E-05 |
| Normal-vs-AfricanAmerican |
1.961760E-02 |
| Normal-vs-Asian |
1.021560E-01 |
| Caucasian-vs-AfricanAmerican |
7.556800E-01 |
| Caucasian-vs-Asian |
4.958000E-02 |
| AfricanAmerican-vs-Asian |
3.244400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.922350E-03 |
| Normal-vs-Female |
9.23670000041454E-07 |
| Male-vs-Female |
9.469600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.247900E-04 |
| Normal-vs-Age(41-60Yrs) |
5.6227999999936E-05 |
| Normal-vs-Age(61-80Yrs) |
1.76337999999721E-05 |
| Normal-vs-Age(81-100Yrs) |
4.361900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.647200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.106100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.874400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.526800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.548200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.862400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.351200E-04 |
| Classical-VS-Follicular |
2.939800E-03 |
| Classical-VS-Other |
8.692400E-01 |
| Classical-VS-Normal |
6.555500E-04 |
| Tall-VS-Follicular |
3.709400E-01 |
| Tall-VS-Other |
2.389600E-01 |
| Tall-VS-Normal |
6.84650000026821E-07 |
| Follicular-VS-Other |
2.737200E-01 |
| Follicular-VS-Normal |
2.11350000001165E-06 |
| Other-VS-Normal |
2.960400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67263999999445E-05 |
| Normal-vs-N1 |
2.251900E-02 |
| N0-vs-N1 |
2.285200E-01 |
|
|
